KL\u0130M\u0130K Derne\u011fi Viral Hepatit \u00c7al\u0131\u015fma Grubu Ba\u015fkan\u0131 Prof. Dr. Ne\u015fe Demirt\u00fcrk, \u201cT\u00fcm d\u00fcnyada viral hepatiti olan 325 milyon insandan neredeyse 300 milyonu hepatit B veya hepatit C oldu\u011funun fark\u0131nda de\u011fil. \u00dclkemizde de \u00e7o\u011fu hen\u00fcz tan\u0131 almam\u0131\u015f 3,5 milyon hepatit B hastas\u0131, 750 bin hepatit C hastas\u0131 oldu\u011fu tahmin edilmekte\u201d dedi.<\/p>\n
KL\u0130M\u0130K Derne\u011fi Viral Hepatit \u00c7al\u0131\u015fma Grubu, 28 Temmuz D\u00fcnya Hepatit G\u00fcn\u00fc dolay\u0131s\u0131yla hepatit hastal\u0131\u011f\u0131na dikkat \u00e7ekti.<\/p>\n
KL\u0130M\u0130K Derne\u011fi Viral Hepatit \u00c7al\u0131\u015fma Grubu Ba\u015fkan\u0131 Prof. Dr. Ne\u015fe Demirt\u00fcrk, \u201cD\u00fcnyada her y\u0131l yakla\u015f\u0131k 1 milyondan fazla ki\u015fi viral hepatitlere ba\u011fl\u0131 siroz ve karaci\u011fer kanseri nedeni ile ya\u015fam\u0131n\u0131 yitirmektedir. \u00dclkemizde de kronik hepatit B ve C enfeksiyonlar\u0131 karaci\u011fer nakillerinin en s\u0131k nedenini olu\u015fturmakta. G\u00fcn\u00fcm\u00fcz ko\u015fullar\u0131nda, hepatit B i\u00e7in etkin bir a\u015f\u0131n\u0131n varl\u0131\u011f\u0131, kronik hepatit C enfeksiyonu i\u00e7in ise tam k\u00fcr sa\u011flayan etkin bir tedavinin varl\u0131\u011f\u0131 bu hastal\u0131klar\u0131n kontrol alt\u0131na al\u0131nabilmesi konusunda elimizi g\u00fc\u00e7lendiren iki \u00f6nemli silah. Ancak ne yaz\u0131k ki t\u00fcm d\u00fcnyada viral hepatiti olan 325 milyon insandan neredeyse 300 milyonu hepatit B veya hepatit C oldu\u011funun fark\u0131nda de\u011fil. \u00dclkemizde de \u00e7o\u011fu hen\u00fcz tan\u0131 almam\u0131\u015f 3,5 milyon hepatit B hastas\u0131, 750 bin hepatit C hastas\u0131 oldu\u011fu tahmin edilmekte. Bu nedenle viral hepatitli hastalar\u0131n tespiti ve tedavisi viral hepatitlerle sava\u015fta kilit noktay\u0131 olu\u015fturmakta\u201d \u015feklinde konu\u015ftu.<\/p>\n
Hepatit , hastalar\u0131 doktora getirecek a\u011f\u0131r semptomlara neden olmuyor<\/p>\n
Hepatit hastalar\u0131n\u0131n tesad\u00fcfen fark edildi\u011fini belirten Prof. Dr. Ne\u015fe Demirt\u00fcrk, \u201cViral hepatit yapan etkenler, ayr\u0131nt\u0131l\u0131 olarak tan\u0131mlanm\u0131\u015f olan tan\u0131 testleri ile kolayl\u0131kla saptanabilmektedir. B\u00f6ylece viral hepatit olgulara kolayca ve g\u00fcvenilir bir \u015fekilde tan\u0131 konulabilmektedir. Ancak kronik viral hepatitler, hastalar\u0131 hekime getirecek kadar a\u011f\u0131r semptomlara yol a\u00e7mad\u0131klar\u0131 i\u00e7in hastalar genellikle tesad\u00fcfen saptanmaktad\u0131r. Bu durum da bir \u00e7ok hastan\u0131n hastal\u0131\u011f\u0131n\u0131n fark\u0131nda olmadan ya\u015fam\u0131n\u0131 s\u00fcrd\u00fcrmesine neden olmaktad\u0131r. D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc viral hepatitlerin azalt\u0131lmas\u0131 i\u00e7in, 2016 y\u0131l\u0131nda 194 \u00fclkenin kat\u0131l\u0131m\u0131yla 2016-2021 y\u0131llar\u0131 aras\u0131nda uygulanacak olan bir eliminasyon program\u0131 ba\u015flatt\u0131. Bu program\u0131n hedefi 2030 y\u0131l\u0131na kadar viral hepatitlere ba\u011fl\u0131 \u00f6l\u00fcmlerin y\u00fczde 65, yeni olgu say\u0131s\u0131n\u0131n ise y\u00fczde 90 azalt\u0131lmas\u0131 olarak belirlendi. Bu hedefe ula\u015fmak i\u00e7in DS\u00d6 taraf\u0131ndan \u00f6ncelenen konular; infantlarda HBV a\u015f\u0131lamas\u0131, HBV ta\u015f\u0131y\u0131c\u0131s\u0131 annelerden bebeklere ge\u00e7i\u015fin engellenmesi, g\u00fcvenli kan transf\u00fczyonlar\u0131, g\u00fcvenli enjeksiyonlar, damar i\u00e7i ila\u00e7 kullan\u0131c\u0131lar\u0131nda enjekt\u00f6r payla\u015f\u0131m\u0131n\u0131n engellenmesi, kronik HBV ve HCV hastalar\u0131n\u0131n tan\u0131 ve tedaviye ula\u015f\u0131m\u0131n\u0131n sa\u011flanmas\u0131 olarak se\u00e7ildi. Belirlenen hedeflere ula\u015fmak i\u00e7in \u00f6ncelikle hem sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131 hem de toplumda viral hepatitlerle ilgili fark\u0131ndal\u0131\u011f\u0131n artt\u0131r\u0131lmas\u0131 ve risk gruplar\u0131n\u0131n belirlenerek bu ki\u015filerde tarama \u00e7al\u0131\u015fmalar\u0131n\u0131n yap\u0131lmas\u0131 \u00f6zellikle \u00f6nem ta\u015f\u0131maktad\u0131r\u201d dedi.<\/p>\n
28 Temmuz D\u00fcnya Hepatit G\u00fcn\u00fc<\/p>\n
28 Temmuz D\u00fcnya Hepatit G\u00fcn\u00fc konusuna de\u011finen Prof. Dr. Ne\u015fe Demirt\u00fcrk, \u201c28 Temmuz viral hepatitlerle ilgili fark\u0131ndal\u0131\u011f\u0131n artt\u0131r\u0131lmas\u0131 i\u00e7in D\u00fcnya Hepatit G\u00fcn\u00fc olarak belirlenmi\u015ftir. Bu g\u00fcn arac\u0131l\u0131\u011f\u0131 ile viral hepatitler konusunda toplumun e\u011fitimine daha fazla yer verilmesi, ulusal taramalar\u0131n art\u0131r\u0131lmas\u0131 ve toplumun bu taramalara kat\u0131lmas\u0131n\u0131n sa\u011flanmas\u0131 ama\u00e7lanmaktad\u0131r. DS\u00d6\u2019n\u00fcn viral hepatit eliminasyon hedeflerine ula\u015fabilmek i\u00e7in \u00fclkemizde de Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan ge\u00e7ti\u011fimiz y\u0131l, 2018-2023 y\u0131llar\u0131 aras\u0131n\u0131 hedefleyen \u201cT\u00fcrkiye Viral Hepatit \u00d6nleme ve Kontrol Program\u0131\u201d yay\u0131nlanm\u0131\u015ft\u0131r. Bu program \u00e7er\u00e7evesinde; toplumun viral hepatitlerin bula\u015f yollar\u0131 ve korunma konular\u0131nda bilgilendirilmesi, y\u00fcksek riskli gruplar\u0131n tan\u0131mlanmas\u0131 ve bu ki\u015filerde viral hepatit taramalar\u0131n\u0131n ger\u00e7ekle\u015ftirilmesi, \u00fclkemizdeki ger\u00e7ek hasta say\u0131s\u0131n\u0131n belirlenmesi i\u00e7in surveyans\u0131n etkin \u015fekilde yap\u0131lmas\u0131, hastalar\u0131n tespiti sonras\u0131 tedavi i\u00e7in do\u011fru y\u00f6nlendirilmelerinin sa\u011flanmas\u0131 ama\u00e7lanmaktad\u0131r. T\u00fcm bu hedeflerin ger\u00e7ekle\u015ftirilmesi i\u00e7in konu ile ilgili t\u00fcm sa\u011fl\u0131k birimlerinin koordine \u00e7al\u0131\u015fmas\u0131 b\u00fcy\u00fck \u00f6nem ta\u015f\u0131makta\u201d \u015feklinde konu\u015ftu.<\/p>\n
Hastalara ula\u015f\u0131lmas\u0131 , hepatit eliminasyonunun anahtar noktas\u0131<\/p>\n
Bu y\u0131l da D\u00fcnya Hepatit G\u00fcn\u00fc\u2019nde amac\u0131n olabildi\u011fince \u00e7ok ki\u015fiye ula\u015farak toplumun viral hepatitler<\/p>\n
konusundaki bilgi d\u00fczeyinin artt\u0131r\u0131lmas\u0131 oldu\u011funu belirten Prof. Dr. Ne\u015fe Demirt\u00fcrk, \u201cHasta ki\u015filere y\u00fcksek oranlarda ula\u015f\u0131labilmesi, hepatit eliminasyonunun anahtar noktas\u0131. DS\u00d6, e\u011fer d\u00fcnya genelinde tan\u0131 oranlar\u0131nda kitlesel bir art\u0131\u015fa gidilemez ise tedavi oranlar\u0131n\u0131n d\u00fc\u015fece\u011fi, infeksiyon oranlar\u0131n\u0131n y\u00fckselece\u011fi ve 2030 y\u0131l\u0131na dek d\u00fcnya genelinde hepatitleri yok etme f\u0131rsat\u0131n\u0131n kaybedilece\u011fini bildirmektedir. KL\u0130M\u0130K Derne\u011fi Viral Hepatit \u00c7al\u0131\u015fma Grubu olarak 28 temmuz 2019 D\u00fcnya hepatit g\u00fcn\u00fcnde, bireysel ve toplumsal d\u00fczeyde tan\u0131 testlerinin yap\u0131lmas\u0131 ve hastalar\u0131n tedaviye y\u00f6nlendirilmesi konusunun \u00f6nemini tekrar hat\u0131rlatmak istedik. Hastalar\u0131 saptamak i\u00e7in riskli gruplarda hepatit taramalar\u0131 yapmal\u0131y\u0131z\u201d dedi.<\/p>\n
2030 y\u0131l\u0131na kadar hepatitlerin yok edilmesi ama\u00e7lan\u0131yor<\/p>\n
Ayr\u0131ca Prof. Dr. Ne\u015fe Demirt\u00fcrk, \u201cDS\u00d6\u2019n\u00fcn 2030 y\u0131l\u0131na kadar hepatitleri yok etme stratejisini, 2016 y\u0131l\u0131nda 194 \u00fclke benimsemi\u015f olsa da \u015fu ana kadar \u00e7ok az \u00fclke bu hedefe ula\u015fmak i\u00e7in gerekli ulusal d\u00fczenlemeleri yapm\u0131\u015ft\u0131r. \u00dclkemizde Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 taraf\u0131ndan yay\u0131nlanan \u201cT\u00fcrkiye Viral Hepatit \u00d6nleme Ve Kontrol Program\u0131\u201d da ancak ger\u00e7ek ya\u015fama aktar\u0131labildi\u011fi \u00f6l\u00e7\u00fcde ba\u015far\u0131l\u0131 olacakt\u0131r. Bu konuda viral hepatit tan\u0131 ve tedavisi ile u\u011fra\u015fan t\u00fcm hekimlere \u00e7ok \u00f6nemli g\u00f6revler d\u00fc\u015fmekte.<\/p>\n
KL\u0130M\u0130K Derne\u011fi Viral Hepatit \u00c7al\u0131\u015fma Grubu, iki y\u00fcz yetmi\u015f iki hekim \u00fcyesiyle kuruldu\u011fu 2011 y\u0131l\u0131ndan bu yana yeni olgu say\u0131s\u0131n\u0131n azalt\u0131lmas\u0131, \u00f6zellikle hepatit B ve C enfeksiyonu olan hastalar\u0131n tan\u0131 almas\u0131n\u0131n sa\u011flanmas\u0131, bu hastalar\u0131n tedaviye ula\u015fabilmesi konular\u0131nda aktif \u00e7al\u0131\u015fmalar\u0131n\u0131 s\u00fcrd\u00fcrmektedir. D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc hepatit eliminasyon hedeflerine ula\u015f\u0131lmas\u0131 i\u00e7in KL\u0130M\u0130K \u00e7at\u0131s\u0131 alt\u0131nda \u00e7al\u0131\u015fmalar\u0131n\u0131 giderek artan bir ivme y\u00fcr\u00fcten VH\u00c7G olarak, 2019 D\u00fcnya hepatit g\u00fcn\u00fcnde de bireysel \u00e7aban\u0131n \u00f6nemini vurgulamak, hastalar\u0131n bulunmas\u0131 ve toplumun fark\u0131ndal\u0131\u011f\u0131n\u0131n artt\u0131r\u0131lmas\u0131 konusunda hep birlikte \u00e7al\u0131\u015fman\u0131n gereklili\u011fini hat\u0131rlatmak isteriz\u201d diye konu\u015ftu.<\/p>\n","protected":false},"excerpt":{"rendered":"
KL\u0130M\u0130K DERNE\u011e\u0130 V\u0130RAL HEPAT\u0130T \u00c7ALI\u015eMA GRUBU BA\u015eKANI PROF. DR. NE\u015eE DEM\u0130RT\u00dcRK, \u201cT\u00dcM D\u00dcNYADA V\u0130RAL HEPAT\u0130T\u0130 OLAN 325 M\u0130LYON \u0130NSANDAN NEREDEYSE 300 M\u0130LYONU HEPAT\u0130T B VEYA HEPAT\u0130T C OLDU\u011eUNUN FARKINDA DE\u011e\u0130L. \u00dcLKEM\u0130ZDE DE \u00c7O\u011eU HEN\u00dcZ TANI ALMAMI\u015e 3,5 M\u0130LYON HEPAT\u0130T B HASTASI, 750 B\u0130N HEPAT\u0130T C HASTASI OLDU\u011eU TAHM\u0130N ED\u0130LMEKTE\u201d DED\u0130.<\/p>\n","protected":false},"author":1,"featured_media":186972,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[1],"tags":[216,322,46501,6333,4523,2603,46500,41794,2750,35841],"class_list":["post-186971","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-genel","tag-baskani","tag-calisma","tag-demirturk","tag-dernegi","tag-grubu","tag-hepatit","tag-klimik","tag-nese","tag-prof","tag-viral"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.tvturk.com\/wp-content\/uploads\/2019\/07\/klimik-dernegi-viral-hepatit-calisma-grubu-baskani-prof-nese-demirturk_8b461bd.jpg?fit=1000%2C667","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/paKIfm-MDF","_links":{"self":[{"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/posts\/186971","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/comments?post=186971"}],"version-history":[{"count":0,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/posts\/186971\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/media\/186972"}],"wp:attachment":[{"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/media?parent=186971"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/categories?post=186971"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/tags?post=186971"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}